Home/Publications

Eight hundred and fifty papers —
including the ones that failed

Publication bias is one of the most damaging forces in regenerative medicine. A field that only reports its successes cannot correct itself, so we publish the null results too.

850+ Papers 28 Patents 60+ Journals Open Access Where Funded
  • 0+Total Publications
  • 0+Papers in 2025
  • 0Patents Filed
  • 0+Journals

Archive

Selected publications

Full text is available on request for any paper listed. Filter by research domain.

252025
Cell Therapy

Mesenchymal Stem Cells in Tissue Regeneration: A Ten-Year Outcome Review

Journal of Regenerative MedicineKumar R, Nair M, et al.
Request PDF
252025
Immunology

Platelet-Derived Factors and Immune Modulation in Chronic Inflammation

Cell Therapy JournalSheikh F, Raj A, et al.
Request PDF
252025
Orthobiologics

Adipose-Derived Stem Cells in Bone Regeneration: A Randomised Controlled Trial

Regenerative BiologyMenon A, Iyer V, et al.
Request PDF
252025
Null Result

No Measurable Benefit of Adjunct PRP in Rotator Cuff Repair: A Negative Trial

Orthopaedic Research InternationalMathew J, Menon A, et al.
Request PDF
242024
Biomaterials

Degradable Hydrogel Scaffolds for Critical-Size Defect Repair

Biomaterials ScienceRao L, Verma S, et al.
Request PDF
242024
Cell Therapy

Donor Variability in Mesenchymal Stromal Cell Potency: Why Protocols Fail to Replicate

Stem Cells Translational MedicineKumar R, Pillai N, et al.
Request PDF
242024
Orthobiologics

Standardising Platelet-Rich Plasma Preparation: A Multi-Centre Comparison

Orthopaedic Research InternationalMenon A, Mathew J, et al.
Request PDF
232023
Immunology

Extracellular Vesicles as a Cell-Free Alternative in Regenerative Therapy

Journal of Extracellular VesiclesNair M, Sheikh F, et al.
Request PDF
232023
Biomaterials

Scaffold Stiffness as a Determinant of Osteogenic Commitment

Tissue Engineering Part ARao L, Raj A, et al.
Request PDF

Our Position

How we publish

Four rules that occasionally cost us a favourable headline.

  • 01

    Pre-registration

    Every clinical protocol is registered before recruitment opens, so the endpoints cannot quietly change once the data arrives.

  • 02

    Null results published

    Studies that fail to show benefit are written up and submitted like any other. Four of our 2025 papers report no effect.

  • 03

    Declared conflicts

    Funding sources and commercial interests are disclosed on every paper, including where a sponsor supplied materials.

  • 04

    Data availability

    De-identified datasets are shared with qualified researchers on request, under a standard data transfer agreement.

Request full-text access

Send us the title and your affiliation and we will forward the paper, usually within a working day.

Request a Paper